Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
An Exploratory Study on Individualized Neoadjuvant Treatment Regimens for Early HR+/HER2+ Breast Cancer
ClinicalTrials.gov study NCT07300215. IPD Sharing: YES. Countries: 0. Publications: 0.
HR Chest CT Visual Scoring, Spirometry and Health Related Quality of Life in Evaluating Severity of ILD Patients
ClinicalTrials.gov study NCT05999838. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy
ClinicalTrials.gov study NCT02142868. IPD Sharing: Not stated. Countries: 2. Publications: 0.
HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy
ClinicalTrials.gov study NCT05322720. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Palbociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Adv
ClinicalTrials.gov study NCT07340658. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer
ClinicalTrials.gov study NCT05577442. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy in Neoadjuvant Treatment of HR+/HER2- Breast Cancer Patients
ClinicalTrials.gov study NCT07197697. IPD Sharing: YES. Countries: 0. Publications: 0.
Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer
ClinicalTrials.gov study NCT07305246. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Retrospective Analysis of Effectiveness and Safety Profile of Anastrozole and Letrozole in HR+ Breast Cancer Patients
ClinicalTrials.gov study NCT02812277. IPD Sharing: NO. Countries: 0. Publications: 0.
Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy
ClinicalTrials.gov study NCT07190651. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer
ClinicalTrials.gov study NCT05044988. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer
ClinicalTrials.gov study NCT05889871. IPD Sharing: NO. Countries: 0. Publications: 0.
AZA+Lus VS AZA Monotherapy in HR-MDS
ClinicalTrials.gov study NCT06927232. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.
ClinicalTrials.gov study NCT02154776. IPD Sharing: NO. Countries: 2. Publications: 0.
Probiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses
ClinicalTrials.gov study NCT06245486. IPD Sharing: NO. Countries: 0. Publications: 0.
Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy
ClinicalTrials.gov study NCT03638648. IPD Sharing: NO. Countries: 0. Publications: 0.
Neoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT06639672. IPD Sharing: NO. Countries: 0. Publications: 0.
Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer
ClinicalTrials.gov study NCT06254066. IPD Sharing: NO. Countries: 0. Publications: 0.
To Assess the Bioequivalence of Test Oral Formulation of Alpha Lipoic Acid 600 mg HR Film Coated Tablets of Ilko Ilac San. Ve Tic. A.S. Versus Reference Thioctacid (Alpha Lipoic Acid) 600 mg HR Film C
ClinicalTrials.gov study NCT04214665. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer
ClinicalTrials.gov study NCT05808582. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.